Belgian biotechnology company Galapagos (GLPG.BT) Wednesday said it will buy GlaxoSmithKline's (GSK) research center in Zagreb, Croatia.

MAIN FACTS:

-XXXXX

-The deal is expected to be effective as of 9 September 2010. It will provide ongoing employment of the staff at the center and add capacity for Galapagos' growing R&D requirements.

-Terms of the deal include the acquisition of the research center along with the transfer of approximately 130 staff. In addition, Galapagos will provide R&D services to GSK under a three year fee-for-service contract to the value of EUR14 million. Further terms were not disclosed.

-By Brussels Bureau, Dow Jones Newswires; +322 741 1480;
Galapagos (EU:GLPG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Galapagos Charts.
Galapagos (EU:GLPG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Galapagos Charts.